South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- UMOA financial market: 3,076 billion CFA francs of public securities issuances projected by the States for the 2nd quarter of 2026
- The ECOWAS Bank for Investment and Development and the republic of Guinea forge strategic partnership to accelerate economic transformation
- Standard Bank closes record $800 million sustainable loan
- WAICA Re Kenya: Net profit up to approximately USD 4.4 million in 2025 and strengthening of equity
- Togo Media Foot Festival formalizes a strategic agreement with Coris Bank International Togo
- Uganda: Citibank chosen to raise $3.2 billion to revive the mega SGR railway project
- Nigeria: Public debt increases to 111 billion USD by the end of 2025
- Ivory Coast: Microfinance savings approach one billion dollars in 2025
